Skip to main content
Headlines

In the News

In the News highlights media coverage featuring the Johns Hopkins Bloomberg School of Public Health.

Forbes
|

FDA Advisory Panel Endorses Omicron-Specific Covid Boosters—Here’s When You Should Get Your Next Shot

An advisory panel to the Food and Drug Administration on Tuesday recommended the agency push to field new COVID-19 booster shots targeting the highly contagious omicron variant, a move some hope will offer a boost in the fight against the rapidly evolving coronavirus—but the most vulnerable populations shouldn’t wait till the fall to get an updated shot, experts say.
 

The Guardian
|

US bans Juul but young vapers are already switching to newer products

The US effectively banned Juul after the FDA ordered the e-cigarette maker to remove its popular products from the marketplace. Experts have hailed the move as significant. But they are also concerned that such efforts are failing to keep up with a fast-moving vaping industry – one where young people leap quickly from one product to another.
 

Associated Press
|

American Medical Association weighs in

Thursday’s Supreme Court ruling that struck down a New York gun law requiring people to demonstrate a particular need for carrying a gun in order to get a license to carry one in public has no immediate impact on other laws, including rules on background checks and age requirements for gun purchases.
 

Slate
|

Should Your Kids Get Moderna or Pfizer?

As with their adult counterparts, the kids’ editions of the Pfizer and Moderna vaccines are not identical. Here, we break down everything we know about the options, including some pros and cons you might want to consider if you have a choice of which kind of vaccine appointment to book.
 

The New York Times
|

Tattoo Artists Face a Grayer Palette in Europe

The E.U. has prohibited some pigments, deeming them potentially hazardous to humans. Artists and manufacturers around the world are struggling to find replacements.